Michael J. Mcelhaugh serves as Executive at Arbutus Biopharma Corp, where they oversee executive responsibilities. Since joining the company, Michael J. Mcelhaugh has executed 7 insider transactions totaling $423.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2024 involved selling 10,164 shares valued at $23.5K.
Michael J. Mcelhaugh currently holds 1,504,793 shares of Arbutus Biopharma Corp (ABUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Mcelhaugh has been a net seller of ABUS stock. They have purchased $0 and sold $423.7K worth of shares.
Michael J. Mcelhaugh's most recent insider trade was on Feb 2, 2024, when they sold 10,164 shares at $2.31 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| Feb 1, 2023 | ABUS | $0 | Award | 83,700 | $N/A | Discretionary |
| Feb 9, 2021 | ABUS | $100.0K | Sale | 20,000 | $5.00 | Discretionary |
| Dec 14, 2020 | ABUS | $150.0K | Sale | 30,000 | $5.00 | Discretionary |
| Dec 14, 2020 | ABUS | $50.0K | Sale | 10,000 | $5.00 | Discretionary |
| Jul 23, 2020 | ABUS | $100.2K | Sale | 20,000 | $5.01 | Discretionary |